Koninklijke Philips NV vs ProShares Ultra Gold ETF — how do they compare? Koninklijke Philips NV trades at $26.3 (market cap $25.89B), while ProShares Ultra Gold ETF trades at $45.87. The key difference: Koninklijke Philips NV pays a 3.81% dividend while ProShares Ultra Gold ETF pays none. Which is the better fit depends on your goals.
| PHG | UGL | |
|---|---|---|
Market Cap | $25.89B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $32.91 | $85.62 |
52-Week Low | $25.02 | $33.59 |
Enterprise Value | $32.18B | — |
Dividend Yield | 3.81% | — |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
UGL (ProShares Ultra Gold) trades at $43.39, down 0.41% on the day, with technical indicators showing a bearish trend from moving averages but neutral oscillators. The ETF lacks fundamental financial ratios like P/E or P/B as it tracks gold futures. Recent news highlights gold's volatility amid Middle East tensions and interest rate uncertainty, with some analysts seeing a potential rebound from oversold conditions.
Outlook remains mixed: gold's safe-haven demand supports upside, but higher interest rates pose headwinds. Risks include Fed policy shifts and geopolitical developments. Institutional sentiment is cautious, with technicals favoring short-term bearishness despite some oversold signals suggesting potential stabilization.
Trailing returns across standard periods
Latest headlines on both assets
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →